⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11495911 | 1.00 | — | — | |
| SCHEMBL165058 | 1.00 | — | — | |
| SCHEMBL24160898 | 0.71 | — | — | |
| SCHEMBL15771139 | 0.70 | — | — | |
| SCHEMBL309226 | 0.70 | — | — | |
| SCHEMBL15770544 | 0.70 | — | — | |
| SCHEMBL309227 | 0.70 | — | — | |
| SCHEMBL15770545 | 0.70 | — | — | |
| SCHEMBL309228 | 0.70 | — | — | |
| SCHEMBL359274 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3421470-B1 | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM | ADVERIO PHARMA GMBH (DE) | 2021-01-20 | — | — | EP | disclosed |
| US-10633356-B2 | Hydrates of substituted 5-fluoro-1H-pyrazolopyridines | ADVERIO PHARMA GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| US-10633357-B2 | Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridines | ADVERIO PHARMA GMBH (DE) | 2020-04-28 | — | — | US | disclosed |
| US-10364229-B2 | Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing | ADVERIO PHARMA GMBH (DE) | 2019-07-30 | — | — | US | disclosed |
| US-20190177288-A1 | INTERMEDIATES AND PROCESS FOR PREPARING INTERMEDIATES IN THE PRODUCTION OF SUBSTITUTED PYRAZOLOPYRIDINES | ADVERIO PHARMA GMBH (DE) | 2019-06-13 | — | — | US | disclosed |
| EP-3421470-A1 | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM | Adverio Pharma GmbH (DE) | 2019-01-02 | — | — | EP | disclosed |
| EP-2758059-B1 | SUBSTITUTED PYRIMIDINES | MERCK SHARP & DOHME (US) | 2018-10-24 | — | — | EP | disclosed |
| EP-2782914-B1 | METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES | ADVERIO PHARMA GMBH (DE) | 2018-08-01 | — | — | EP | disclosed |
| US-20180065942-A1 | CRYSTALLINE SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND PROCESS FOR PREPARING | ADVERIO PHARMA GMBH (DE) | 2018-03-08 | — | — | US | disclosed |
| US-20180065942-A1 | CRYSTALLINE SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND PROCESS FOR PREPARING | ADVERIO PHARMA GMBH (DE) | 2018-03-08 | — | — | US | disclosed |
| WO-2013043624-A1 | SUBSTITUTED PYRIMIDINES | MERCK SHARP & DOHME CORP. (US) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013030288-A1 | SUBSTITUTED ANNELLATED PYRIMIDINE AND THE USE THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-03-07 | — | — | WO | disclosed |
| WO-2012004258-A9 | RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-06-07 | — | — | WO | disclosed |
| WO-2012028647-A1 | BICYCLIC AZA HETEROCYCLES, AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012028645-A1 | METHOD FOR THE PRODUCTION OF 5-FLUORO-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBONITRILE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012004258-A1 | RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-12 | — | — | WO | disclosed |
| US-7812022-B2 | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors | GLAXOSMITHKLINE LLC (US) | 2010-10-12 | — | — | US | disclosed |
| US-20080051395-A1 | 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2008-02-28 | — | — | US | disclosed |
| US-4992592-A | 1-fluoro-1-halo-3,6-dioxabicyclo [4.1.0]heptane preparation, process and use | RHONE-POULENC CHIMIE (FR) | 1991-02-12 | — | — | US | disclosed |
| EP-0029282-B1 | PROCESS FOR PREPARING 5-HALOPYRIMIDINES AND 5-PYRIMIDINE METHANOLS | ELI LILLY AND COMPANY (US) | 1983-05-18 | — | — | EP | disclosed |